Clinical Trial Update: Efficacy of Adding Topiramate to Current Treatment in Treatment-Resistant Generalized Social Phobia (GSP) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy of adding topiramate to current treatment for treatment-resistant generalized social phobia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Phobia

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: McMaster University | Conditions: Social Phobia | Phase 4 | Status: TERMINATED